These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of Compound 21, a Selective Angiotensin II Type 2 Receptor Agonist, in a Murine Xenograft Model of Dupuytren Disease. Chisholm J; Gareau AJ; Byun S; Paletz JL; Tang D; Williams J; LeVatte T; Bezuhly M Plast Reconstr Surg; 2017 Nov; 140(5):686e-696e. PubMed ID: 29068929 [TBL] [Abstract][Full Text] [Related]
8. A role for metformin in the treatment of Dupuytren disease? Baeri A; Levraut M; Diazzi S; Camuzard O; Cegarra-Escolano M; Ploumellec MA; Balaguer T; Fassy J; Rezzonico R; Bellusci S; Mari B; Vassaux G Biomed Pharmacother; 2022 Jun; 150():112930. PubMed ID: 35427821 [TBL] [Abstract][Full Text] [Related]
9. Wnt pathway in Dupuytren disease: connecting profibrotic signals. van Beuge MM; Ten Dam EJ; Werker PM; Bank RA Transl Res; 2015 Dec; 166(6):762-771.e3. PubMed ID: 26470681 [TBL] [Abstract][Full Text] [Related]
10. Collagenase Clostridium histolyticum for the Treatment of Distal Interphalangeal Joint Contractures in Dupuytren Disease. Fei TT; Chernoff E; Monacco NA; Komatsu DE; Muhlrad S; Sampson SP; Hurst LC; Dagum AB J Hand Surg Am; 2019 May; 44(5):417.e1-417.e4. PubMed ID: 30146387 [TBL] [Abstract][Full Text] [Related]
11. Let's Focus on the Fibrosis in Dupuytren Disease: Cell Communication Network Factor 2 as a Novel Target. Lambi AG; Morrell NT; Popoff SN; Benhaim P; Barbe MF J Hand Surg Glob Online; 2023 Sep; 5(5):682-688. PubMed ID: 37790821 [TBL] [Abstract][Full Text] [Related]
13. The contractile properties and responses to tensional loading of Dupuytren's disease--derived fibroblasts are altered: a cause of the contracture? Bisson MA; Mudera V; McGrouther DA; Grobbelaar AO Plast Reconstr Surg; 2004 Feb; 113(2):611-21; discussion 622-4. PubMed ID: 14758224 [TBL] [Abstract][Full Text] [Related]
14. Continuous Passive Elongation Through an External Fixator: A Versatile and Beneficial Adjunct Technique to Treat Severe and Recurrent Cases of Dupuytren Contracture. Chan PY; Marcus A; Tan V Tech Hand Up Extrem Surg; 2023 Jun; 27(2):125-130. PubMed ID: 36534764 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials. Badalamente MA; Hurst LC; Benhaim P; Cohen BM J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533 [TBL] [Abstract][Full Text] [Related]
16. The effect of a therapy protocol for increasing correction of severely contracted proximal interphalangeal joints caused by dupuytren disease and treated with collagenase injection. Skirven TM; Bachoura A; Jacoby SM; Culp RW; Osterman AL J Hand Surg Am; 2013 Apr; 38(4):684-9. PubMed ID: 23474162 [TBL] [Abstract][Full Text] [Related]
17. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers. Pess GM; Pess RM; Pess RA J Hand Surg Am; 2012 Apr; 37(4):651-6. PubMed ID: 22464232 [TBL] [Abstract][Full Text] [Related]
18. Outcomes and Early Recurrence Following Enzymatic (Collagenase) Treatment of Moderate and Severe Dupuytren Contractures. David M; Smith G; Pinder R; Craigen M; Waldram M; Mishra A; Dickson D; Wu F; Brewster M J Hand Surg Am; 2020 Dec; 45(12):1187.e1-1187.e11. PubMed ID: 32861504 [TBL] [Abstract][Full Text] [Related]